Medicare Part D overpaid millions of dollars for prescription drugs that should have been covered by the Medicare Part A hospice benefit, according to a recent report from the Office of Inspector General (OIG), which conducted an audit from 2016 payments. In other words, CMS paid twice for the same drugs.

CVS Health announced a $2 million contribution to an existing $50 million campaign to end e-cigarette use, known as vaping, among teenagers. The announcement comes at a time when hundreds of lung disease injuries linked to vaping have appeared in dozens of states.

Purdue Pharma, the maker of popular opioid OxyContin, is preparing to file for bankruptcy before the end of September if the company doesn’t reach a settlement over thousands of lawsuits against the company for its role in the opioid abuse epidemic, Reuters reported, citing people familiar with the matter.

Health insurance giant and care services provider Humana has joined the Consumer Technology Association, marking the first time a payer has joined the association.

More than 3,400 drugs saw price hikes in the first half of 2019, with the average increase being more than five times the rate of inflation, according to CVS Caremark.

HHS Secretary Alex Azar declared public health emergencies for Georgia and South Carolina on Sept. 2 in preparation for Hurricane Dorian.

The wearable technology market reached $23 billion in 2018 and is projected to more than double to $54 billion by 2023, according to a new report from GlobalData.

HHS has jumped into the fray over the ongoing investigation into e-cigarettes amid more than 200 lung disease injuries associated with vaping. As of Aug. 27, 215 possible cases of pulmonary illnesses, including one death, have been reported across 25 states.